Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation

Thoracic and Cardiovascular Surgeon

Volumn 54, Issue 1, 2006, Pages 26-33

  Godje, Oliver ^a,c   Gallmeier, U ^a   Schelian, M ^a   Grunewald M ^a   Mair, H ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Uhlandring 35 ^*  (Germany)

Author keywords

Blood transfusion; Extracorporeal circulation; Factor XIII; Postoperative bleeding

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 CONCENTRATE; BLOOD CLOTTING FACTOR 13A; PLACEBO; PROTAMINE;

ADULT; AGED; ARTICLE; BLOOD SUBSTITUTION; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DIAGNOSTIC VALUE; DOUBLE BLIND PROCEDURE; EXTRACORPOREAL CIRCULATION; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EXTRACORPOREAL CIRCULATION; FACTOR XIII; FIBRINOLYTIC AGENTS; HUMANS; MIDDLE AGED; PLASMIN; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 32544449648     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-872853     Document Type: Article

References (24)

1. Wilhelmi M, Franke U, Cohnret T, Weber P, Kaukemuller J, Fischer S, Wahlers T, Haverich A. Coronary artery bypass grafting surgery without the routine application of blood products: Is it feasible? Eur J Cardiothorac Surg 2001; 19: 657-661
2. McGiIl N, O'Shaughnessy D, Pickering R, Herbertson M, Gill R. Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial. BMJ 2002; 324: 1299
3. Ferraris VA, Ferraris SP, Joseph O, Wehner P, Mentzer RM Jr. Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg 2002; 235: 820-827
4. Ray MJ, Hales MM, Brown L, O'Brien MF, Stafford EG. Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit. Ann Thorac Surg 2001; 72: 521-526
5. Troianos CA, Sypula RW, Lucas DM, D'Amico F, Mathie TB, Desai M, Pasqual RT, Pellegrini RV, Newfeld ML The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting. Anesthesiology 1999; 91: 430-435
6. Locker GJ, Grimm M, Losert H, Stoiser B, Kofler J, Knapp S, Wilfing A, Knoebl P, Kapiotis S, Czerny M, Muhm M, Hiesmayr M, Frass M. Prostaglandin E(1) does not influence plasmatic coagulation, hepatic synthesis, or postoperative blood loss in patients after coronary-artery bypass grafting. J Clin Anesth 2000; 12: 363-370
7. Godje O, Haushofer M, Lamm P, Reichart B. The effect of factor XIII on bleeding in coronary surgery. Thorac Cardiovasc Surg 1998; 46: 263-267
8. Gerlach R, Raabe A, Zimmermann M, Siegemund A, Seifert V. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol 2000; 54: 260-264; discussion 264-265
9. Wozniak G, Noll T, Akinturk H, Thul J, Muller M. Factor XIII prevents development of myocardial edema in children undergoing surgery for congenital heart disease. Ann N Y Acad Sci 2001; 936: 617-620
10. Shainoff JR, Estafanous FG, Yared JP, DiBello PM, Kottke-Marchant K, Loop FD. Low factor XIIIa levels are associated with increased blood loss after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994;108:437-445
11. Levy JH. Efficacy and safety of aprotinine in cardiac surgery. Orthopedics 2004; 27: 659-662
12. Vorstand und Wissenschaftlicher Beirat der Bundesärztekammer. Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. Köln: Deutscher Ärzte-Verlag, 1995
13. Gierhake FW, Papastavrou N, Zimmermann K, Bohn H, Schwick HG. Prophylaxe postoperativer Wundheilungsstörungen durch Faktor XIII Substitution. Dtsch Med Wschr 1974; 99: 1004-1009
14. Homann B, Blumenberg D, Lerner H. Zum Einfluss der Narkose auf den Blutgerinnungsfaktor XIII. Anaesthesist 1984; 33: 145-148
15. Schwarzt ML, Pizzo SV, Hill RL, McKee PA. Human Factor XIII from plasma and platelets. J Biol Chem 1973; 248: 1395-1407
16. Birnbaum D, Betz P. Die extrakorporale Zirkulation als Risikofaktor der Herzchirurgie. Z Kardiol 1990; 79 (Suppl 4): 87-93
17. Tilsner V, Pokar H, Döring V, Reuter H, Marx G. Nichtkardiale Risikofaktoren in der Herzchirurgie - Gerinnungssystem. Z Kardiol 1990; 79(Suppl 4):63-70
18. Boldt J, Schindler E, Welters I, Wittstock M, Stertmann WA, Hempelmann G. The effect of the anticoagulation regimen on endothelial-related coagulation in cardiac surgery patients. Anaesthesia 1995; 50: 954-960
19. Zilla P, Fasol R, Groscurth P, Klepetko W, Reichenspurner H, Wolner E. Blood platelets in cardiopulmonary bypass operations. J Thorac Cardiovasc Surg 1989; 97: 379-388
20. Holloway DS, Summaria L, Sandesare J, Vaagher JP, Alexander JC, Caprini JA. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 1988; 59: 62-67
21. Pleym H, Stenseth R, Wahba A, Bjella L, Tromsdal A, Karevold A, Dale O. Prophylactic treatment with desmopressin does not reduce post-operative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesth Analg 2004; 98: 578-584
22. Centeon Pharma GmbH. Product Information Fibrogammin HS (Factor XIII). Hattersheim, Germany 2004
23. Mishima Y, Nagao F, Ishibiki K, Matsuda M, Nakamura N. Faktor XIII in der Behandlung postoperativer therapierefraktärer Wundheilungsstörungen. Chirurg 1984; 55: 803-808
24. Baer U, Bauknecht J, Stangl T, Häring R. Verminderung postoperativer Wundheilungsstörungen durch prä- oder postoperative quantitative Faktor XIII Substitution. Zbl Chirurgie 1980; 105: 642-651